Eli Lilly (LLY) announced plans to open a new Lilly Gateway Labs site in Philadelphia. The new Gateway Labs site will occupy 44,000 square feet of 2300 Market, a life sciences facility in Center City newly developed and operated by Breakthrough Properties. Biotechs based in the site will have access to dedicated, fully equipped wet lab facilities alongside strategic scientific engagement.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LLY:
- LifeMD price target lowered to $8 from $12 at KeyBanc
- Eli Lilly price target raised to $1,150 from $1,050 at JPMorgan
- Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!
- Eli Lilly Stock (LLY) Falls as Rival Novo Nordisk Cuts Weight-Loss Drug Prices
- Novo launches introductory self-pay offer for Wegovy, Ozempic for $199 per month